Health and Human Services Secretary Sylvia Burwell announced that her department will change regulations that restrict the number of patients who can be prescribed buprenorphine, to the delight of suppliers like BioDelivery Sciences and hopefully to the benefit of the growing number of patients addicted to heroin and opioid-based prescription drugs.
West Pharmaceutical Services is developing an electronic tracking system to track adherence to medication using its self-injection drug delivery system.
French researchers have developed a vaginal ring made from silicone that could deliver preventive treatments for both HIV and herpes. Because it's made of silicone, the ring has the potential to provide care to women at a lower cost than other rings.
Seattle's Impel NeuroPharma raised $4 million in equity, taking its total fundraising haul to nearly $9 million, as it seeks to outlicense its device for overcoming the blood-brain barrier via intranasal drug delivery.
Scientists at the University of California, San Diego, have developed nanoparticles that could act as human platelets in the blood, helping drugs that treat cardiovascular disease and bacterial infections.
The only inhaler that administers a slow-moving mist to help respiratory patients inhale the medication is now FDA-approved for the long-term maintenance treatment of asthma, in addition to its previous indication to treat COPD.
Regenxbio's gene therapy drug delivery tech is licensed to 8 partners, including Baxalta. It is being used by 18 candidates.
Research teams from the U.S. and Ireland are joining forces in the development of nanotechnology to treat pancreatic cancer. With a new grant of £2.9 million ($4.4 million), the international cohort aims to create chemotherapy-delivering treatments for the disease, which has the lowest 5-year survival rate of any common cancer.
By noticing a connection between developing human egg cells and tumor cells, researchers have developed a method of cancer drug delivery that could more selectively target the offending cells and keep healthy tissue safe from harm, possibly preserving fertility, as well.
Ultrasound sonoporation can improve the delivery of chemotherapy drugs in patients with advanced pancreatic cancer thanks to the presence of gaseous microbubbles in commercially available contrast agents, a study presented at the International Contrast Ultrasound Society conference in Chicago suggests
Novo Nordisk and MIT's Langer Lab announced a three-year collaboration focused on developing next-generation drug delivery devices for the administration of peptides using noninjectable methods. There is an option to extend the deal for an additional three years.
AstraZeneca allied with Starpharma on drug delivery, in a licensing deal that could yield the Australian company up to $126 million from the development and commercialization of one of the Big Pharma's oncology candidates, and up to $93.3 million for each subsequent product.
Nicotine isn't the only drug that e-cigarettes can deliver. A study of 3,847 Connecticut high school students found that 28% of e-cigarette users have used the device to vaporize marijuana.
A team of researchers at Columbia University has developed a method of drug delivery to the lungs that could lead to more efficient dosing for many kinds of lung diseases using microvolume liquid concentrations. By delivering drugs directly to the disease site, treatment can be relegated to the necessary areas without causing dangerous side effects in other nearby organs.
Big Pharma Sanofi is seeking to expand its U.K. inhalation and nasal spray center due to increased demand for the drug delivery devices and associated medications, especially those manufactured on behalf of third parties.
A team at Stanford University showed in a diabetic mouse model that they could insert an insulin gene fragment into the liver to stimulate T-regulatory cells into holding T-effector cells at bay, halting the progression of Type 1 diabetes at the early stages of the disease before the symptoms were noticeable.
The first generic version of Novartis' transdermal patch for Alzheimer's has been launched with hopes of getting a slice of the branded med's approximately $400 million in annual sales. Until now Novartis's Exelon Patch was the only transdermal product for the disease on the market.
Sancilio Pharmaceuticals announced its plans for an IPO on the Nasdaq worth up to $86 million in an SEC filing.
The oncology community is divided over intraoperative radiation therapy, which as its name suggests is given at the same time as lumpectomy to breast cancer patients.
Surefire Medical picked up FDA clearance for its embolization device designed to deliver cancer drugs directly to tumors. The 510(k) comes on the heels of clinical data published in the Journal of Vascular and Interventional Radiology.